Under-Represented Communities Diagnosed With SCD or MCI Through Tele-Cog
Part of paid clinical trials in Columbus, Ohio.
- Sponsor
- Ohio State University
- Study ID
- NCT06542458
- Status
- Not Yet Recruiting
Notify me when recruiting opens
Save your spot on the interest list for this study. We'll keep your details with this study so our team can follow up when recruiting opens.
Add your contact details and location so we can keep your interest tied to this study.
Conditions
- Mild Cognitive Impairment
- Subjective Cognitive Decline
Eligibility Criteria
- Sex
- ALL
- Age
- 50 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- Assessments — BEHAVIORALParticipants will undergo a standard battery of neuropsychological measures, behavioral questionnaire, and functional assessment to monitor cognition and function over time. Clinical data obtained as part of standard of care will be collected from the medical record
- Neuroimaging volumetric measures — OTHERNeuroimaging volumetric measures will be obtained from already conducted standard of care neuroimaging.
- Biofluid samples — OTHERBiofluid sampling data will be obtained through another protocol. All participants will be required to sign that consent to participate in this trial.
Study Details
Overall, this study's primary aim is to establish a prospective, longitudinal, observational cohort study of older adults at risk for dementia from under-resourced/underrepresented communities. More specifically, older adults diagnosed with subjective cognitive decline (SCD) or Mild Cognitive Impairment (MCI) during clinical care offered via the Tele-Cog clinic would be recruited for more comprehensive data collection to characterize the clinical presentation and course of illness over multiple timepoints spread out longitudinally.
Key Dates
- Start date
- Dec 1, 2026
- Status verified
- Feb 2026
- Primary completion
- Jan 1, 2032
- Completion
- Jan 1, 2032
Study Design
- Enrollment
- 1,000 participants (estimated)
Arms
- Arm: Study PopulationAdults ages 50 years and older who are fluent in English and are diagnosed with subjective cognitive concerns (SCD) or objective cognitive decline with mostly intact functioning (MCI diagnosis) as part of clinical work up
Primary Outcome Measure
Number of adults with Subjective Cognitive Decline (SCD) or Mild Cognitive Impairment (MCI) at risk for dementia from under-resourced/underrepresented communities that we longitudinally collect clinical data, neuropsychology, neuroimaging, and biofluids [ Time Frame: 5 years ]
Central Contacts
- Jessica Pommy, PhD614-293-4969
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| The Ohio State University | Columbus | Ohio | 43210 | - |
Find similar trials in Columbus, OH
Related Studies
- Determinants of Incident Stroke Cognitive Outcomes and Vascular Effects on RecoverYRecruiting · Massachusetts General Hospital · Phoenix, Arizona
- A Clinical Trial of AAV2-BDNF Gene Therapy in Early Alzheimer's Disease and Mild Cognitive ImpairmentPHASE1 · Recruiting · Mark Tuszynski · La Jolla, California
- Alzheimer's Disease Neuroimaging Initiative 4Enrolling By Invitation · University of Southern California · Birmingham, Alabama
- Anxiety Sensitivity Treatment to Reduce Anxiety in Alzheimer'sRecruiting · Florida State University · Tallahassee, Florida